<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://businessdailyswitzerland.com/article/915688033-sgs-expands-automotive-materials-testing-capabilities-with-new-czech-republic-laboratory</loc>
      <news:news>
        <news:publication>
          <news:name>Business Daily Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-28T11:13:22+00:00</news:publication_date>
        <news:title>SGS expands automotive materials testing capabilities with new Czech Republic laboratory  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24870362-3049-auto-lab-4096x2731.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://businessdailyswitzerland.com/article/915405517-netris-pharma-secures-7-25-million-in-horizon-europe-funding-to-advance-phase-2b-clinical-trial-in-head-and-neck-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Business Daily Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-28T06:00:00+00:00</news:publication_date>
        <news:title>NETRIS Pharma Secures €7.25 Million in Horizon Europe Funding to Advance Phase 2b Clinical Trial in Head and Neck Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/18432937-netris-pharma-logo-1056x174.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://businessdailyswitzerland.com/article/915632078-basilea-erh-lt-weitere-usd-13-mio-von-barda-zur-entwicklung-des-neuartigen-antibiotikums-ceftibuten-ledaborbactam</loc>
      <news:news>
        <news:publication>
          <news:name>Business Daily Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-28T05:15:00+00:00</news:publication_date>
        <news:title>Basilea erhält weitere USD 13 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://businessdailyswitzerland.com/article/915632120-basilea-receives-further-usd-13-million-from-barda-to-continue-development-of-novel-antibiotic-ceftibuten-ledaborbactam</loc>
      <news:news>
        <news:publication>
          <news:name>Business Daily Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-28T05:15:00+00:00</news:publication_date>
        <news:title>Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://businessdailyswitzerland.com/article/915373175-ivybears-emerges-as-breakout-new-animation-ip-with-15m-youtube-views-and-1-9m-trailer-views-ahead-of-episode-two</loc>
      <news:news>
        <news:publication>
          <news:name>Business Daily Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-27T11:44:24+00:00</news:publication_date>
        <news:title>IvyBears Emerges as Breakout New Animation IP With 15M+ YouTube Views and 1.9M Trailer Views Ahead of Episode Two</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24868214-ivybears-2912x1632.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://businessdailyswitzerland.com/article/915249667-molecular-partners-to-present-at-td-cowen-s-7th-annual-oncology-innovation-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Business Daily Switzerland</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-26T20:00:00+00:00</news:publication_date>
        <news:title>Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
